Company / Free Cash Flow per Share
Incyte Free Cash Flow per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$1.28
FY2024
5-year range
$1.28 / $4.04
FY2020-FY2024
Trend
-
vs FY2023
Sector context
#42 of 192
Health Care
What the data says
Incyte's free cash flow per share of $1.28 is higher than 78% of companies in the Health Care sector (FY2024). Free Cash Flow per Share has fluctuated over the past 8 years, ranging from $-1.08 in FY2017 to $4.04 in FY2022.
Based on SEC 10-K filings.
1.28 in FY2024 with a 3-year CAGR of -21.0%. Top quartile in the Health Care sector.
Declined from $2.59 to $1.28 over the past 3 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -21.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+106.4% above sector average
Key checks
Key Insights
- Ranks #42 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.7%
- Strong return on equity: 25.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.28 | - |
| FY2023 | - | - |
| FY2022 | $4.04 | +55.8% |
| FY2021 | $2.59 | +113.1% |
| FY2020 | $1.22 | +227.1% |
| FY2019 | -$0.96 | -176.9% |
| FY2018 | $1.24 | +215.1% |
| FY2017 | -$1.08 | -209.3% |
| FY2016 | $0.99 | +166.4% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026